Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets
Résumé
A correct clinical diagnosis in the early stage of Alzheimer disease (AD) is mandatory given the current available treatment with acetylcholine esterase inhibitors. Moreover, a early to preclinical diagnosis would allow to identify patients eligible for future disease-modifying therapies.
Origine : Fichiers produits par l'(les) auteur(s)
Loading...